AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 76-100/160

Authors: FALCHERO L COIFFIER B GUIBERT B SOUQUET PJ PINET SI TRILLETLENOIR V
Citation: L. Falchero et al., MALIGNANT PLEURAL MESOTHELIOMA FOLLOWING RADIOTHERAPY FOR HODGKINS-DISEASE, Bulletin du cancer, 83(11), 1996, pp. 964-968

Authors: SALLES G BIENVENU J BASTION Y BARBIER Y DOCHE C WARZOCHA K GUTOWSKI MC RIEUX C COIFFIER B
Citation: G. Salles et al., ELEVATED CIRCULATING LEVELS OF TNF-ALPHA AND ITS P55 SOLUBLE RECEPTORARE ASSOCIATED WITH AN ADVERSE PROGNOSIS IN LYMPHOMA PATIENTS, British Journal of Haematology, 93(2), 1996, pp. 352-359

Authors: HIDDEMANN W LONGO DL COIFFIER B FISHER RI CABANILLAS F CAVALLI F NADLER LM DEVITA VT LISTER TA ARMITAGE JO
Citation: W. Hiddemann et al., LYMPHOMA CLASSIFICATION - THE GAP BETWEEN BIOLOGY AND CLINICAL MANAGEMENT IS CLOSING, Blood, 88(11), 1996, pp. 4085-4089

Authors: DUMONTET C DRAI J BASTION Y BERARD N SALLES G COIFFIER B
Citation: C. Dumontet et al., ALTERED LDH ISOENZYME PROFILES IN THE SERUM OF PATIENTS WITH AGGRESSIVE LYMPHOMA, Blood, 88(10), 1996, pp. 3458-3458

Authors: ROCHANT H FENAUX P GUERCI A COIFFIER B DREYFUS F BELANGER C ELONEN E KANGASAHO M JOUHIKAINEN T
Citation: H. Rochant et al., RESULTS OF HEME ARGINATE TREATMENT OF MYELODYSPLASTIC SYNDROMES - A MULTICENTER PHASE-II STUDY OF THE FRENCH GROUP OF MYELODYSPLASTIC SYNDROMES, Blood, 88(10), 1996, pp. 3566-3566

Authors: GISSELBRECHT C LEPAGE E MOREL P LEDERLIN P COIFFIER B TILLY H BOSLY A GABARRE J BRIERE J FILLET G MOLINA T REVES F
Citation: C. Gisselbrecht et al., INTENSIFIED INDUCTION-PHASE INCLUDING AUTOLOGOUS PERIPHERAL STEM-CELLTRANSPLANTATION DOES NOT IMPROVE RESPONSE RATE AND SURVIVAL IN LYMPHOMA WITH AT LEAST 2 ADVERSE PROGNOSTIC FACTORS WHEN COMPARED TO ACVB REGIMEN, Blood, 88(10), 1996, pp. 470-470

Authors: THIEBLEMONT C BERGER F BASTION Y SALLES G DUMONTET C RIEUX C FELMAN P COIFFIER B
Citation: C. Thieblemont et al., MUCOSA-ASSOCIATED LYMPHOID-TISSUE (MALT) GASTROINTESTINAL AND NONGASTROINTESTINAL LYMPHOMA - COMPARISON OF INITIAL PICTURE AND OUTCOME IN 108 PATIENTS, Blood, 88(10), 1996, pp. 898-898

Authors: GISSELBRECHT C GAULARD P LEPAGE E COIFFIER B BRIERE FJ HAIOUN C CAZALS D BOSLY A XERRI L TILLY H BERGER F BOUHABDALLAH R DIEBOLD J
Citation: C. Gisselbrecht et al., PROGNOSTIC-SIGNIFICANCE OF T-CELL PHENOTYPE IN AGGRESSIVE NON-HODGKINS-LYMPHOMAS, Blood, 88(10), 1996, pp. 1159-1159

Authors: COIFFIER B ANDERSON J ARMITAGE J BERGER F CAVALLI F CHAN W CLOSE P CONNORS J DIEBOLD J GASCOYNE R HARRIS N HIDDEMANN W HO F JACOBS P LIANG R LISTER A MACCLENNAN K MULLERHERMELINK H NATHWANI B NORTON A OTT G PEDRINIS E ROSENBERG S ROY P SCHAUER A WEISENBURGER D
Citation: B. Coiffier et al., CLINICAL PROGNOSTIC FACTORS ARE STRONGER PREDICTORS OF OUTCOME IN NON-HODGKINS-LYMPHOMA (NHL) THEN PATHOLOGICAL SUBTYPE, Blood, 88(10), 1996, pp. 1160-1160

Authors: NEIDHARDTBERARD EM GARCIA E DURAND I COIFFIER B SALLES G BANCHEREAU J GARRONE P
Citation: Em. Neidhardtberard et al., RESISTANCE TO FAS-INDUCED APOPTOSIS IN CD40-ACTIVATED B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS, Blood, 88(10), 1996, pp. 1174-1174

Authors: WARZOCHA K RENARD N CHARLOT C BIENVENU J COIFFIER B SALLES G
Citation: K. Warzocha et al., LYMPHOTOXIN-ALPHA (LT-ALPHA) AND LYMPHOTOXIN-BETA (LT-BETA) GENES EXPRESSION IN TRANSFORMED-CELL LINES AND NON-HODGKINS-LYMPHOMAS - PRESENCE OF AN ALTERNATIVELY SPLICED FORM OF LT-BETA, Blood, 88(10), 1996, pp. 1497-1497

Authors: WARZOCHA K RENARD N CHARLOT C BIENVENU J BASTION Y NEIDHARTBERARD EM DUMONTET C COIFFIER B SALLES G
Citation: K. Warzocha et al., THE TUMOR-NECROSIS-FACTOR, LYMPHOTOXIN AND FAS LIGAND-RECEPTOR SYSTEMGENES EXPRESSION IN NON-HODGKINS-LYMPHOMAS, Blood, 88(10), 1996, pp. 1498-1498

Authors: SOLALCELIGNY P LEPAGE E BROUSSE N TERTIAN G THYSS A REMAN O SEBBAN C PIGNON B GISSELBRECHT C COIFFIER B COLE B SUGANO D TENDLER C
Citation: P. Solalceligny et al., A DOXORUBICIN CONTAINING REGIMEN WITH OR WITHOUT INTERFERON-ALPHA-2B (IFN-ALPHA 2B) IN ADVANCED FOLLICULAR LYMPHOMAS - FINAL ANALYSIS OF SURVIVAL, TOXICITY AND QUALITY-OF-LIFE OF THE GELF86 TRIAL, Blood, 88(10), 1996, pp. 1800-1800

Authors: ARCHIMBAUD E PHILIP I COIFFIER B MICHALLET M SALLES G SEBBAN C ROUBI N LOPEZ F BESSUEILLE L MAZARS P JUTTNER C ATKINSON K PHILIP T
Citation: E. Archimbaud et al., CD34(-) PERIPHERAL-BLOOD STEM-CELLS (PBSC) TRANSPLANTATION AFTER HIGH-DOSE THERAPY FOR PATIENTS WITH MULTIPLE MYUELOMA()THY1(+)LIN(), Blood, 88(10), 1996, pp. 2370-2370

Authors: HIDDEMANN W BRITTINGER G TIEMANN M PARWARESCH R STEIN H LISTER AT NORTON A PITTALUGA S DEWOLFPEETERS C VANHOOF A COIFFIER B BERGER F KLUINNELEMANNS H VANKRIEKEN H KLUIN P CAVALLI F ROGGERO E PEDRINIS E MONTSERRAT E PIRIS MA UNTERHALT M
Citation: W. Hiddemann et al., CLINICAL CHARACTERISTICS AND RESPONSE TO CHEMOTHERAPY OF MANTLE CELL LYMPHOMAS - RESULTS OF A EUROPEAN SURVEY, Blood, 88(10), 1996, pp. 2683-2683

Authors: WILLIAMS CD TAGHIPOUR G LISTER TA BLYSTAAD AM COIFFIER B GOLDSTONE AH
Citation: Cd. Williams et al., CHEMOSENSITIVE TRANSFORMED FOLLICULAR NON-HODGKINS-LYMPHOMA (NHL) IS A FIRM-INDICATION FOR HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION - A STUDY FROM THE EBMT REGISTRY, Blood, 88(10), 1996, pp. 2727-2727

Authors: COIFFIER B
Citation: B. Coiffier, SHOULD VINDESINE BE USED IN STANDARD CHEMOTHERAPY REGIMENS FOR LYMPHOMA, Journal of drug development and clinical practice, 7(3), 1995, pp. 151-158

Authors: WARZOCHA K BIENVENU J COIFFIER B SALLES G
Citation: K. Warzocha et al., MECHANISMS OF ACTION OF THE TUMOR-NECROSIS-FACTOR AND LYMPHOTOXIN LIGAND-RECEPTOR SYSTEM, European cytokine network, 6(2), 1995, pp. 83-96

Authors: MARICHY C DUMONTET C BASTION Y RIEUX C BLAY JY SALLES G BIRON P COIFFIER B
Citation: C. Marichy et al., HEPATIC ANGIOSARCOMA IN A PATIENT WITH ESSENTIAL THROMBOCYTHEMIA AND BUDD-CHIARI SYNDROME, European journal of cancer, 31A(3), 1995, pp. 423-423

Authors: COIFFIER B
Citation: B. Coiffier, TOWARDS A CURE IN INDOLENT LYMPHOPROLIFERATIVE DISEASES, European journal of cancer, 31A(13-14), 1995, pp. 2135-2137

Authors: FERME C BASTION Y LEPAGE E BERGER F BRICE P MOREL P GABARRE J NEDELLEC G REMAN O CHERON N OBERLIN O COIFFIER B
Citation: C. Ferme et al., THE MINE REGIMEN AS INTENSIVE SALVAGE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY HODGKINS-DISEASE, Annals of oncology, 6(6), 1995, pp. 543-549

Authors: COIFFIER B HIDDEMANN W STEIN H
Citation: B. Coiffier et al., MANTLE CELL LYMPHOMA - A THERAPEUTIC DILEMMA, Annals of oncology, 6(3), 1995, pp. 208-210

Authors: COIFFIER B
Citation: B. Coiffier, 14 YEARS OF HIGH-DOSE CHOP (ACVB REGIMEN) - PRELIMINARY CONCLUSIONS ABOUT THE TREATMENT OF AGGRESSIVE-LYMPHOMA PATIENTS, Annals of oncology, 6(3), 1995, pp. 211-217

Authors: ZUCCA E STEIN H COIFFIER B
Citation: E. Zucca et al., FURTHER CONFUSION IN THE LITERATURE ON MANTLE CELL LYMPHOMA SHOULD BEAVOIDED, Annals of oncology, 6(3), 1995, pp. 305-306

Authors: BASTION Y DHEDIN N FELMAN P COIFFIER B
Citation: Y. Bastion et al., THE MANAGEMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA - A CASE, Annals of oncology, 6(1), 1995, pp. 71-76
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>